| ΕΠΩΝΥΜΙΑ
ΕΤΑΙΡΕΙΑΣ |
ΚΥΚΛΟΣ ΕΡΓΑΣΙΩΝ
(ΠΩΛΗΣΕΙΣ) 2012 |
ΚΥΚΛΟΣ ΕΡΓΑΣΙΩΝ
(ΠΩΛΗΣΕΙΣ) 2011 |
ΜΕΤΑΒΟΛΗ
2012/2011 (%) |
ΚΕΡΔΗ ΠΡΟ ΦΟΡΩΝ
2012 |
ΚΕΡΔΗ ΠΡΟ ΦΟΡΩΝ
2011 |
ΜΕΤΑΒΟΛΗ
2012/2011 (%) |
| NOVARTIS (HELLAS) ΑEBE |
410.100.943 |
440.206.939 |
-6,84 |
1.021.788 |
12.072.862 |
-91,54 |
| ΠΦΑΪΖΕΡ ΕΛΛΑΣ ΑΕ |
345.984.871 |
446.059.319 |
-22,44 |
27.968.511 |
-50.324.907 |
- |
| SANOFI AVENTIS ΑEBΕ |
251.955.492 |
274.897.960 |
-8,35 |
-5.965.617 |
-15.622.474 |
61,81 |
| BOEHRINGER INGELHEIM ΕΛΛΑΣ ΑE |
244.803.844 |
215.710.390 |
13,49 |
12.961.131 |
10.729.293 |
20,80 |
| ΒΙΑΝΕΞ ΑE |
240.194.300 |
301.894.558 |
-20,44 |
27.618.935 |
30.466.771 |
-9,35 |
| GLAXOSMITHKLINE AΕ&ΒΕ |
208.547.775 |
224.151.059 |
-6,96 |
31.756.125 |
15.677.818 |
102,55 |
| ROCHE (HELLAS) ΑΕ |
193.981.609 |
234.844.690 |
-17,40 |
-226.237 |
-61.535.248 |
99,63 |
| MERCK SHARP & DOHME "MSD" ΑΕ |
186.200.134 |
162.969.037 |
14,25 |
44.442.612 |
-6.086.457 |
- |
| ASTRAZENECA ΑE |
184.924.576 |
203.883.157 |
-9,30 |
-1.666.112 |
8.486.071 |
- |
| ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑE |
182.274.448 |
207.439.159 |
-12,13 |
74.358.929 |
-89.322.352 |
- |
| ABBOTT LABORATORIES (ΕΛΛΑΣ) ΑΒΕΕ |
166.711.067 |
192.383.156 |
-13,34 |
12.667.406 |
-25.210.088 |
- |
| ΦΑΡΜΑΤΕΝ ΑΒΕΕ |
149.321.132 |
108.479.936 |
37,65 |
10.500.225 |
7.183.493 |
46,17 |
| BAYER ΕΛΛΑΣ ΑΒΕΕ |
145.883.835 |
165.694.308 |
-11,96 |
3.264.532 |
12.139.813 |
-73,11 |
| ΦΑΡΜΑΣΕΡΒ - ΛΙΛΛΥ ΑΕΒΕ |
129.477.067 |
158.505.154 |
-18,31 |
4.834.428 |
6.145.885 |
-21,34 |
| ΦΑΜΑΡ ΑΒΕ |
120.931.814 |
123.915.454 |
-2,41 |
9.333.618 |
2.769.266 |
237,04 |
|
|
|
|
|
|
|
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου